Annual Total Liabilities
$206.59 M
+$65.67 M+46.60%
December 31, 2023
Summary
- As of February 7, 2025, KYTX annual total liabilities is $206.59 million, with the most recent change of +$65.67 million (+46.60%) on December 31, 2023.
- During the last 3 years, KYTX annual total liabilities has risen by +$74.85 million (+56.82%).
- KYTX annual total liabilities is now at all-time high.
Performance
KYTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$36.49 M
+$6.88 M+23.23%
September 30, 2024
Summary
- As of February 7, 2025, KYTX quarterly total liabilities is $36.49 million, with the most recent change of +$6.88 million (+23.23%) on September 30, 2024.
- Over the past year, KYTX quarterly total liabilities has dropped by -$170.11 million (-82.34%).
- KYTX quarterly total liabilities is now -82.34% below its all-time high of $206.59 million, reached on December 31, 2023.
Performance
KYTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
KYTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.6% | -82.3% |
| 3 y3 years | +56.8% | -82.3% |
| 5 y5 years | +56.8% | -82.3% |
KYTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +56.8% | -82.3% | +25.8% |
| 5 y | 5-year | at high | +56.8% | -82.3% | +25.8% |
| alltime | all time | at high | +56.8% | -82.3% | +25.8% |
Kyverna Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $36.49 M(+23.2%) |
| Jun 2024 | - | $29.61 M(+2.1%) |
| Mar 2024 | - | $28.99 M(-86.0%) |
| Dec 2023 | $206.59 M | $206.59 M(+1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $204.29 M(+45.0%) |
| Dec 2022 | $140.92 M(+7.0%) | - |
| Dec 2022 | - | $140.92 M |
| Dec 2021 | $131.74 M | - |
FAQ
- What is Kyverna Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Kyverna Therapeutics?
- What is Kyverna Therapeutics annual total liabilities year-on-year change?
- What is Kyverna Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Kyverna Therapeutics?
- What is Kyverna Therapeutics quarterly total liabilities year-on-year change?
What is Kyverna Therapeutics annual total liabilities?
The current annual total liabilities of KYTX is $206.59 M
What is the all time high annual total liabilities for Kyverna Therapeutics?
Kyverna Therapeutics all-time high annual total liabilities is $206.59 M
What is Kyverna Therapeutics annual total liabilities year-on-year change?
Over the past year, KYTX annual total liabilities has changed by +$65.67 M (+46.60%)
What is Kyverna Therapeutics quarterly total liabilities?
The current quarterly total liabilities of KYTX is $36.49 M
What is the all time high quarterly total liabilities for Kyverna Therapeutics?
Kyverna Therapeutics all-time high quarterly total liabilities is $206.59 M
What is Kyverna Therapeutics quarterly total liabilities year-on-year change?
Over the past year, KYTX quarterly total liabilities has changed by -$170.11 M (-82.34%)